Adj. Q1 sales +79% q-o-q and +45% vs. ABGSCe… …but lower gross margins than expected Ovzon-3 to be l...
Redeye changes its sales forecast and fair value range after weaker-than-expected sales for Q1 while...
Enersense’s Q1 profitability figures beat our estimates but cost inflation can hurt figures more dur...
Exel’s EBIT appears bound to improve more from the recent lows.
Strong Q1’22 beat – revenues 54% higher than cons. New orders in Q1, driven by higher-margin segment...
Solid operational performance and project progress +100bps interest rate to our ’24e impacts CEPS by...
The underlying demand for Vaisala’s applications continued strong.
We expected soft Q1 sales due to the Omicron wave in early Q1.
Europe and RoW improving both sales and adj. EBITA Strong gross (59.
Strong aftermarket recovery behind 40% org. growth Russian sales offset by stronger aftermarket; EBI...
Redeye returns with a second comment following Alelion’s Q1(22) report with actual figures in line w...
Sdiptech delivered a solid Q1 report, with EBITA* in line with our expectations.
Q1 performance OK given the circumstances Resetting growth expectations Comforting words on use of s...
Obducat publicerade idag den 29 april 2022 sin delårsrapport för första kvartalet 2022, vilken visad...
Prevas startade 2022 starkt med ökad marginal, ökad omsättning, ökning av antalet anställda och fort...
Fortsatt god organisk tillväxt Med 12% organisk tillväxt växte omsättningen med 18% till 190 mkr (16...
Redeye sees a solid Q1 report with MRR, sales and EBIT in line with our expectations.
Redeye states that the Q4 report was mixed with a slightly better sales development but weaker profi...
Försäljningen backar Arcomas försäljning för Q1'22 uppgick till 24,3 mkr (36,9 mkr) vilket var ca 6%...
Rental income +5% vs ABGSCe Some questions around higher costs ~50% below peers on ’22e P/EPRA NRV ...
